- Home
- ALTS vs VTGN Comparison
ALTS vs VTGN Comparison
Compare ALTS & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALTS
- VTGN
- Stock Information
- Founded
- ALTS 1976
- VTGN 1998
- Country
- ALTS United States
- VTGN United States
- Employees
- ALTS N/A
- VTGN N/A
- Industry
- ALTS
- VTGN Biotechnology: Pharmaceutical Preparations
- Sector
- ALTS
- VTGN Health Care
- Exchange
- ALTS NYSE
- VTGN Nasdaq
- Market Cap
- ALTS 159.4M
- VTGN 70.0M
- IPO Year
- ALTS N/A
- VTGN N/A
- Fundamental
- Price
- ALTS $7.88
- VTGN $2.04
- Analyst Decision
- ALTS
- VTGN
- Analyst Count
- ALTS 0
- VTGN 0
- Target Price
- ALTS N/A
- VTGN N/A
- AVG Volume (30 Days)
- ALTS 295.1K
- VTGN 186.8K
- Earning Date
- ALTS 08-18-2025
- VTGN 08-12-2025
- Dividend Yield
- ALTS N/A
- VTGN N/A
- EPS Growth
- ALTS N/A
- VTGN N/A
- EPS
- ALTS N/A
- VTGN N/A
- Revenue
- ALTS $18,046,000.00
- VTGN $486,000.00
- Revenue This Year
- ALTS $185.91
- VTGN N/A
- Revenue Next Year
- ALTS $64.93
- VTGN $943.32
- P/E Ratio
- ALTS N/A
- VTGN N/A
- Revenue Growth
- ALTS N/A
- VTGN N/A
- 52 Week Low
- ALTS $1.29
- VTGN $1.90
- 52 Week High
- ALTS $10.95
- VTGN $4.21
- Technical
- Relative Strength Index (RSI)
- ALTS 45.07
- VTGN 41.01
- Support Level
- ALTS $6.62
- VTGN $1.97
- Resistance Level
- ALTS $10.38
- VTGN $2.12
- Average True Range (ATR)
- ALTS 1.07
- VTGN 0.14
- MACD
- ALTS -0.34
- VTGN -0.02
- Stochastic Oscillator
- ALTS 30.14
- VTGN 20.00
About ALTS ALT5 SIGMA CORPORATION
ALT5 Sigma Corp is a fintech company. The company operates in three operating segments: Fintech: provides next generation blockchain-powered technologies for tokenization, trading, clearing, settlement, payment, and safe-keeping of digital assets, Biotechnology: Biotechnology segment is focused on finding treatments for conditions that cause severe pain and bringing to market drugs with non-addictive pain-relieving properties; Corporate and Others: Corporate and Other segment consists of certain corporate general and administrative costs. Company has revenue from Fintech Segment.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.